These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 3514729

  • 1. Similarities and differences in the antihypertensive effect of two calcium antagonist drugs, verapamil and nifedipine.
    Agabiti-Rosei E, Muiesan ML, Romanelli G, Castellano M, Beschi M, Corea L, Muiesan G.
    J Am Coll Cardiol; 1986 Apr; 7(4):916-24. PubMed ID: 3514729
    [Abstract] [Full Text] [Related]

  • 2. Adrenergic activity and left ventricular function during treatment of essential hypertension with calcium antagonists.
    Muiesan G, Agabiti-Rosei E, Romanelli G, Muiesan ML, Castellano M, Beschi M.
    Am J Cardiol; 1986 Feb 26; 57(7):44D-49D. PubMed ID: 3006466
    [Abstract] [Full Text] [Related]

  • 3. Acute and chronic effects of nifedipine on plasma renin activity and plasma adrenaline and noradrenaline in controls and hypertensive patients.
    Corea L, Miele N, Bentivoglio M, Boschetti E, Agabiti-Rosei E, Muiesan G.
    Clin Sci (Lond); 1979 Dec 26; 57 Suppl 5():115s-117s. PubMed ID: 396062
    [Abstract] [Full Text] [Related]

  • 4. Antihypertensive and humoral effects of verapamil and nifedipine in essential hypertension.
    Muiesan G, Agabiti-Rosei E, Castellano M, Alicandri CL, Corea L, Fariello R, Beschi M, Romanelli G.
    J Cardiovasc Pharmacol; 1982 Dec 26; 4 Suppl 3():S325-9. PubMed ID: 6184562
    [Abstract] [Full Text] [Related]

  • 5. Comparison of cardiovascular, renal, and humoral effects of acute administration of two calcium channel blockers in normotensive and hypertensive subjects.
    Leonetti G, Cuspidi C, Sampieri L, Terzoli L, Zanchetti A.
    J Cardiovasc Pharmacol; 1982 Dec 26; 4 Suppl 3():S319-24. PubMed ID: 6184561
    [Abstract] [Full Text] [Related]

  • 6. Comparison of two calcium blockers on hemodynamics, left ventricular mass, and coronary vasodilatory in advanced hypertension.
    Diamond JA, Krakoff LR, Goldman A, Coplan N, Gharavi A, Martin K, Goldsmith R, Henzlova MJ, Machac J, Phillips RA.
    Am J Hypertens; 2001 Mar 26; 14(3):231-40. PubMed ID: 11281234
    [Abstract] [Full Text] [Related]

  • 7. Hypotensive action of calcium antagonists as related to plasma noradrenaline and reactivity to noradrenaline.
    Schwietzer G, Distler A, Reeck S, Thiede HM, Philipp T.
    J Hypertens Suppl; 1983 Dec 26; 1(2):102-4. PubMed ID: 6400109
    [Abstract] [Full Text] [Related]

  • 8. Comparative acute effects of the calcium channel blockers tiapamil, nisoldipine, and nifedipine on blood pressure and some regulatory factors in normal and hypertensive subjects.
    Laederach K, Weidmann P, Lauener F, Gerber A, Ziegler WH.
    J Cardiovasc Pharmacol; 1986 Dec 26; 8(2):294-302. PubMed ID: 2422467
    [Abstract] [Full Text] [Related]

  • 9. [The effect of fenigidin (nifedipine) and verapamil on renin activity, the levels of ionized calcium and aldosterone in the blood plasma and on the hemodynamic indices of rats with spontaneous hypertension].
    Nasyrov ShN, Shvarts GIa, Kukes VG, Faermark IF, Siubaev RD.
    Farmakol Toksikol; 1990 Dec 26; 53(1):32-5. PubMed ID: 2184050
    [Abstract] [Full Text] [Related]

  • 10. Calcium blockade in arterial hypertension. Review.
    Lederballe Pedersen O.
    Hypertension; 1983 Dec 26; 5(4 Pt 2):II74-9. PubMed ID: 6222972
    [Abstract] [Full Text] [Related]

  • 11. [Calcium antagonists in the therapy of hypertension].
    Heidland A, Heidbreder E, Hörl WH, Schäfer RM.
    Klin Wochenschr; 1983 Jul 01; 61(13):633-40. PubMed ID: 6350692
    [Abstract] [Full Text] [Related]

  • 12. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
    de Champlain J, Karas M, Nguyen P, Cartier P, Wistaff R, Toal CB, Nadeau R, Larochelle P.
    J Hypertens; 1998 Nov 01; 16(11):1357-69. PubMed ID: 9856375
    [Abstract] [Full Text] [Related]

  • 13. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
    de Champlain J, Karas M, Nguyen P, Cartier P, Wistaff R, Toal CB, Nadeau R, Larochelle P.
    J Hypertens; 1998 Sep 01; 16(9):1357-69. PubMed ID: 9746123
    [Abstract] [Full Text] [Related]

  • 14. Plasma renin activity and norepinephrine as predictors for antihypertensive effects of nifedipine and captopril.
    Kusaka M, Atarashi K, Matsumoto K, Sumida Y, Matsuura H, Shingu T, Kajiyama G.
    Am J Hypertens; 1991 Sep 01; 4(9):735-9. PubMed ID: 1930858
    [Abstract] [Full Text] [Related]

  • 15. Factors influencing the hypotensive effects of calcium antagonists.
    Erne P, Bolli P, Bertel O, Hulthen UL, Kiowski W, Muller FB, Buhler F.
    Hypertension; 1983 Sep 01; 5(4 Pt 2):II97-102. PubMed ID: 6345378
    [Abstract] [Full Text] [Related]

  • 16. Verapamil but not nifedipine impairs left ventricular function during exercise in hypertensive patients.
    Ashmore RC, Corkadel LK, Green CL, Horwitz LD.
    Am Heart J; 1990 Mar 01; 119(3 Pt 1):636-41. PubMed ID: 2309606
    [Abstract] [Full Text] [Related]

  • 17. Calcium-entry blocking agents in the treatment of systemic hypertension.
    Robinson BF.
    Am J Cardiol; 1985 Jan 25; 55(3):102B-106B. PubMed ID: 2857516
    [Abstract] [Full Text] [Related]

  • 18. Effect of a calcium entry blocker on blood pressure, plasma renin activity, aldosterone and catecholamines in normotensive subjects.
    Saito I, Takeshita E, Saruta T, Nagano S, Sekihara T.
    Clin Endocrinol (Oxf); 1986 May 25; 24(5):565-70. PubMed ID: 3539413
    [Abstract] [Full Text] [Related]

  • 19. Cardiovascular effects of verapamil in essential hypertension.
    Städler P, Leonardi L, Riesen W, Ziegler W, Marone C, Beretta-Piccoli C.
    Clin Pharmacol Ther; 1987 Nov 25; 42(5):485-92. PubMed ID: 3315389
    [Abstract] [Full Text] [Related]

  • 20. Antihypertensive effect of fractionated sublingual administration of nifedipine in moderate essential hypertension.
    Thibonnier M, Bonnet F, Corvol P.
    Eur J Clin Pharmacol; 1980 Nov 25; 17(3):161-4. PubMed ID: 6988222
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.